Page 39 - Read Online

Page 334 Breis et al. Neuroimmunol Neuroinflammation 2020;7:330-4 I http://dx.doi.org/10.20517/2347-8659.2020.14

3. Pinatel D, Hivert B, Saint-Martin M, Noraz N, Savvaki M, et al. The Kv1-associated molecules TAG-1 and Caspr2 are selectively
targeted to the axon initial segment in hippocampal neurons. J Cell Sci 2017;130:2209-20.
4. Irani SR, Vincent A. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol
2016;133:185-97.
5. Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E. Caspr2 autoantibodies target multiple epitopes. Neurol Neuroimmunol
Neuroinflamm 2015;2:e127.
6. Saint-Martin M, Pieters A, Déchelotte B, Malleval C, Pinatel D, et al. Impact of anti-CASPR2 autoantibodies from patients with
autoimmune encephalitis on CASPR2/TAG-1 interaction and Kv1 expression. J Autoimmun 2019;103:102284.
7. Binks S, Varley J, Lee W, Makuch M, Elliott K, et al. Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain
2018;141:2263-71.
8. Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, et al. Hippocampal epileptogenesis in autoimmune encephalitis. Ann Clin Transl
Neurol 2019;6:2261-9.
9. Koneczny I. A new classification system for IgG4 autoantibodies. Front Immunol 2018;9:97.
10. Dawes JM, Weir GA, Middleton SJ, Patel R, Chisholm KI, et al. Immune or genetic-mediated disruption of CASPR2 causes pain
hypersensitivity due to enhanced primary afferent excitability. Neuron 2018;97:806-22.e10.
11. Loane C, Argyropoulos GPD, Roca-Fernández A, Lage C, Sheerin F, et al. Hippocampal network abnormalities explain amnesia after
VGKCC-Ab related autoimmune limbic encephalitis. J Neurol Neurosurg Psychiatry 2019;90:965-74.
12. Nikolaus M, Jackowski-Dohrmann S, Prüss H, Schuelke M, Knierim E. Morvan syndrome associated with CASPR2 and LGI1 antibodies
in a child. Neurology 2018;90:183-5.
13. Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J
Neurol Neurosurg Psychiatry 2018;89:526-34.
14. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann
Neurol 2012;72:241-55.
15. Vale TC, Pedroso JL, Dutra LA, Azevedo L, Filho LH, et al. Morvan syndrome as a paraneoplastic disorder of thymoma with anti-
CASPR2 antibodies. Lancet 2017;389:1367-8.
16. Sawlani K, Katirji B. Peripheral nerve hyperexcitability syndromes. Continuum (Minneap Minn) 2017;23:1437-50.
17. Ahmed A, Simmons Z. Isaacs syndrome: a review. Muscle Nerve 2015;52:5-12.
18. Song J, Jing S, Quan C, Lu J, Qiao X, et al. Isaacs syndrome with CASPR2 antibody: a series of three cases. J Clin Neurosci 2017;41:63-6.
19. Chandra SR, Ray S, Isaac T, R Pai A, Krishnareddy H, et al. A clinical TRIAD for early suspicion of autoimmune encephalitis as a
possibility in patients presenting with progressive cognitive decline. Asian J Psychiatr 2019;41:5-12.
20. Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, et al. Autoimmune encephalitis: a review of diagnosis and treatment. Arq
Neuropsiquiatr 2018;76:41-9.
21. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich,
glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia.
Brain 2010;133:2734-48.
22. Montojo MT, Petit-Pedrol M, Graus F, Dalmau J. Clinical spectrum and diagnostic value of antibodies against the potassium channel
related protein complex. Neurologia 2015;30:295-301.
23. Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, et al. Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-
associated encephalitis. Neurol Neuroimmunol Neuroinflamm 2017;4:e371.
24. Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert
Rev Neurother 2015;15:1391-419.